Do research participants share genomic screening results with family members?
- PMID: 34665896
- PMCID: PMC8983417
- DOI: 10.1002/jgc4.1511
Do research participants share genomic screening results with family members?
Abstract
The public health impact of genomic screening can be enhanced by cascade testing. However, cascade testing depends on communication of results to family members. While the barriers and facilitators of family communication have been researched following clinical genetic testing, the factors impacting the dissemination of genomic screening results are unknown. Using the pragmatic Electronic Medical Records and Genomics Network-3 (eMERGE-3) study, we explored the reported sharing practices of participants who underwent genomic screening across the United States. Six eMERGE-3 sites returned genomic screening results for mostly dominant medically actionable disorders and surveyed adult participants regarding communication of results with first-degree relatives. Across the sites, 279 participants completed a 1-month and/or 6-month post-results survey. By 6 months, only 34% of the 156 respondents shared their results with all first-degree relatives and 4% did not share with any. Over a third (39%) first-degree relatives were not notified of the results. Half (53%) of participants who received their results from a genetics provider shared them with all first-degree relatives compared with 11% of participants who received their results from a non-genetics provider. The most frequent reasons for sharing were a feeling of obligation (72%) and that the information could help family members make medical decisions (72%). The most common reasons indicated for not sharing were that the family members were too young (38%), or they were not in contact (25%) or not close to them (25%). These data indicate that the professional returning the results may impact sharing patterns, suggesting that there is a need to continue to educate healthcare providers regarding approaches to facilitate sharing of genetic results within families. Finally, these data suggest that interventions to increase sharing may be universally effective regardless of the origin of the genetic result.
Keywords: cascade testing; communication; family; population screening; predictive genetic testing.
© 2021 National Society of Genetic Counselors.
Conflict of interest statement
CONFLICT OF INTEREST
Julia Wynn, Hila Milo Rasouly, Tania Vasquez-Loarte, Robyn Weiss, Robyn Weiss, Sonja I. Ziniel, Ellen Wright Clayton, Kurt D. Christensen, David Fasel, Robert C. Green, Heather S. Hain, Margaret Harr, Christin Hoell, Iftikhar J Kullo, Kathleen A. Leppig, Melanie F. Myers, Joel E. Pacyna, Emma F. Perez, Cynthia A. Prows, Alanna Kulchak Rahm, Gemme Campbell-Salome, Richard R. Sharp, Maureen E Smith, Georgia L. Wiesner, Janet L. Williams, Carrie L. Blout Zawatsky, Ali G. Gharavi, Wendy K. Chung, Ingrid A. Holm, Akilan M. Saami, and Paul S. Appelbaum declare that they have no conflict of interest.
Figures
References
-
- Baroutsou V, Underhill-Blazey ML, Appenzeller-Herzog C, & Katapodi MC (2021). Interventions facilitating family communication of genetic testing results and cascade screening in hereditary breast/ovarian cancer or lynch syndrome: A systematic review and meta-analysis. Cancers, 13(4), 925. 10.3390/cancers13040925 - DOI - PMC - PubMed
-
- Beri N, Patrick-Miller LJ, Egleston BL, Hall MJ, Domchek SM, Daly MB, Ganschow P, Grana G, Olopade OI, Fetzer D, Brandt A, Chambers R, Clark DF, Forman A, Gaber R, Gulden C, Horte J, Long J, Lucas T, … Bradbury AR (2019). Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study. Clinical Genetics, 95(2), 293–301. 10.1111/cge.13474 - DOI - PMC - PubMed
-
- Bradbury AR, Patrick-Miller LJ, Egleston BL, Hall MJ, Domchek SM, Daly MB, Ganschow P, Grana G, Olopade OI, Fetzer D, Brandt A, Chambers R, Clark DF, Forman A, Gaber R, Gulden C, Horte J, Long JM, Lucas T, … Yao X(S (2018). Randomized noninferiority trial of telephone vs in-person disclosure of germline cancer genetic test results. Journal of the National Cancer Institute, 110(9), 985–993. 10.1093/jnci/djy015 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- U01 HG008676/HG/NHGRI NIH HHS/United States
- U01 HG011172/HG/NHGRI NIH HHS/United States
- U01 HG008657/HG/NHGRI NIH HHS/United States
- U01 HG008672/HG/NHGRI NIH HHS/United States
- U01 HG008684/HG/NHGRI NIH HHS/United States
- U01 HG008679/HG/NHGRI NIH HHS/United States
- U01 HG008666/HG/NHGRI NIH HHS/United States
- U54 MD007593/MD/NIMHD NIH HHS/United States
- U01 HG008680/HG/NHGRI NIH HHS/United States
- U01 HG008673/HG/NHGRI NIH HHS/United States
- U01 HG008685/HG/NHGRI NIH HHS/United States
- U01 HG006379/HG/NHGRI NIH HHS/United States
- U01 HG008664/HG/NHGRI NIH HHS/United States
- U01 HG008701/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
